Induction of Mucosal Tolerance to E-Selectin Targets Immunomodulation to Activating Vessel Segments and Prevents Ischemic and Hemorrhagic Stroke

  • H. Takeda
  • M. Spatz
  • C. Ruetzler
  • R. McCarron
  • K. Becker
  • J. Hallenbeck
Conference paper
Part of the Ernst Schering Research Foundation Workshop book series (SCHERING FOUND, volume 47)


Inflammatory and immune reactions at blood vessel segments that lead to local release of proinflammatory cytokines and local activation of luminal endothelium can initiate stroke (Hallenbeck et al. 1988; Libby et al. 1995). These multipotent autocrine or paracrine mediators can regulate expression of leukocyte adhesion molecules, production of other cytokines, growth factors, and chemokines, and production of matrix metalloproteinases in atherosclerosis. Local endothelium integrates extracellular signals and cellular responses in different regions of the vascular tree (Rosenberg and Aird 1999). Scattered perivascular ring patterns of immunoreactive tumor necrosis factor-alpha (TNF-α), heme oxygenase-1 (HO-1), and manganese superoxide dismutase (MnSOD) within the brain parenchyma of normal rats reflect cyclic activation and inactivation of brain vessel segments (Ruetzler et al. 2001). These cycles appear to be more frequent and intense in stroke-prone animals.


Myelin Basic Protein Phate Buffer Saline Intranasal Instillation Mucosal Tolerance Shwartzman Reaction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Akdis CA, Blaser K (2001) Mechanisms of interleukin-10-mediated immune suppression. Immunology 103:131–136PubMedCrossRefGoogle Scholar
  2. Balabanov R, Beaumont T, Dore-Duffy P (1999) Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res 55:578–587PubMedCrossRefGoogle Scholar
  3. Barcellos-Hoff MH, Ehrhart EJ, Kalia M, Jirtle R, Flanders K, Tsang ML (1995) Immunohistochemical detection of active transforming growth factor-beta in situ using engineered tissue. Am J Pathol 147:1228–1237PubMedGoogle Scholar
  4. Becker BF, Heindl B, Kupatt C, Zahler S (2000) Endothelial function and hemostasis. Z Kardiol 89:160–167PubMedGoogle Scholar
  5. Becker KJ, McCarron RM, Ruetzler C, Laban O, Sternberg E, Flanders KC, Hallenbeck JM (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc Natl Acad SciUS A 94:10873–10878PubMedCrossRefGoogle Scholar
  6. Bevilacqua MP (1993) Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 11:767–804PubMedCrossRefGoogle Scholar
  7. Bevilacqua MP, Nelson RM (1993) Selectins. J Clin Invest 91:379–387CrossRefGoogle Scholar
  8. Bevilacqua MP, Stengelin S, Gimbrone MA, Jr, Seed B (1989) Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160–1165PubMedCrossRefGoogle Scholar
  9. Bordron A, Dueymes M, Levy Y, Jamin C, Leroy JP, Piette JC, Shoenfeld Y, Youinou PY (1998) The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 101:2029–2035PubMedCrossRefGoogle Scholar
  10. Bordron A, Revelen R, D’Arbonneau F, Dueymes M, Renaudineau Y, Jamin C, Youinou P (2001) Functional heterogeneity of anti-endothelial cell antibodies. Clin Exp Immunol 124:492–501PubMedCrossRefGoogle Scholar
  11. Chen Y, Inobe J, Marks R, Gonnella P, Kuchroo VK, Weiner HL (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376:177–180PubMedCrossRefGoogle Scholar
  12. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL (1994) Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237–1240PubMedCrossRefGoogle Scholar
  13. Faria AM, Weiner HL (1999) Oral tolerance: mechanisms and therapeutic applications. Adv Immunol 73:153–264PubMedCrossRefGoogle Scholar
  14. George J, Meroni PL, Gilburd B, Raschi E, Harats D, Shoenfeld Y (2000) Anti-endothelial cell antibodies in patients with coronary atherosclerosis. Immunol Lett 73:23–27PubMedCrossRefGoogle Scholar
  15. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742PubMedCrossRefGoogle Scholar
  16. Hallenbeck JM, Dutka AJ, Kochanek PM, Sirén A-L, Pezeshkpour GH, Feuerstein G (1988) Stroke risk factors prepare rat brainstem tissues for modified local Shwartzman reaction. Stroke 19:863–869PubMedCrossRefGoogle Scholar
  17. Hughes CC, Savage CO, Pober JS (1990) The endothelial cell as a regulator of T-cell function. Immunol Rev 117:85–102PubMedCrossRefGoogle Scholar
  18. Labow MA, Norton CR, Rumberger JM, Lombard-Gillooly KM, Shuster DJ, Hubbard J, Bertko R, Knaack PA, Terry RW, Harbison ML, et al (1994) Characterization of E-selectin-deficient mice: demonstration of overlapping function of the endothelial selectins. Immunity 1:709–720PubMedCrossRefGoogle Scholar
  19. Libby P, Sukhova G, Lee RT, Galis ZS (1995) Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol 25 Suppl 2:S9–12CrossRefGoogle Scholar
  20. Liuzzo G, Kopecky SL, Frye RL, O’Fallon WM, Maseri A, Goronzy JJ, Weyand CM (1999) Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 100:2135–2139PubMedCrossRefGoogle Scholar
  21. McCarron RM, Wang L, Cowan EP, Spatz M (1991) Class II MHC antigen expression by cultured human cerebral vascular endothelial cells. Brain Res 566:325–328PubMedCrossRefGoogle Scholar
  22. Metzler B, Wraith DC (1996) Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Ann N Y Acad Sci 778:228–242PubMedCrossRefGoogle Scholar
  23. Miller A, Lider O, Roberts AB, Sporn MB, Weiner HL (1992) Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc Natl Acad Sci U S A 89:421–125PubMedCrossRefGoogle Scholar
  24. Montgomery KF, Osborn L, Hession C, Tizard R, Goff D, Vassallo C, Tan-Pi, Bomsztyk K, Lobb R, Harlan JM, et al (1991) Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Proc Natl Acad Sci U S A 88:6523–6527PubMedCrossRefGoogle Scholar
  25. Okada Y, Copeland BR, Mori E, Tung M-M, Thomas WS, del Zoppo GJ (1994) P-selectin and intercellular adhesion molecule-1 expression after focal brain ischemia and reperfusion. Stroke 25:202–211PubMedCrossRefGoogle Scholar
  26. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, Graham DI (1987) Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiat 50:402–410PubMedCrossRefGoogle Scholar
  27. Pober JS, Cotran RS (1990) Cytokines and endothelial cell biology. Physiol Rev 70:427–451PubMedGoogle Scholar
  28. Prud’homme GJ, Piccirillo CA (2000) The inhibitory effects of transforming growth factor-beta-1 (TGF-betal) in autoimmune diseases. J Autoimmun 14:23–12PubMedCrossRefGoogle Scholar
  29. Rosenberg RD, Aird WC (1999) Vascular-bed-specific hemostasis and hypercoagulable states. N Engl J Med 340:1555–1564PubMedCrossRefGoogle Scholar
  30. Ruetzler CA, Furuya K, Takeda H, Hallenbeck JM (2001) Brain vessels normally undergo cyclic activation and inactivation: evidence from tumor necrosis factor-alpha, heme oxygenase-1, and manganese superoxide dismutase immunostaining of vessels and perivascular brain cells. J Cereb Blood Flow Metab 21:244–252PubMedCrossRefGoogle Scholar
  31. Salmi M, Granfors K, Leirisalo-Repo M, Hamalainen M, MacDermott R, Leino R, Havia T, Jalkanen S (1992) Selective endothelial binding of interleukin-2-dependent human T-cell lines derived from different tissues. Proc Natl Acad Sci U S A 89:11436–11440PubMedCrossRefGoogle Scholar
  32. Siren AL, McCarron R, Wang L, Garcia-Pinto P, Ruetzler C, Martin D, Hallenbeck JM (2001) Proinflammatory cytokine expression contributes to brain injury provoked by chronic monocyte activation. Mol Med 7:219–229PubMedGoogle Scholar
  33. von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343:1020–1034CrossRefGoogle Scholar
  34. von Asmuth EJ, Smeets EF, Ginsel LA, Onderwater JJ, Leeuwenberg JF, Buurman WA (1992) Evidence for endocytosis of E-selectin in human endothelial cells. Eur J Immunol 22:2519–2526CrossRefGoogle Scholar
  35. Weiner HL (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335–343PubMedCrossRefGoogle Scholar
  36. Weyand CM, Goronzy JJ, Liuzzo G, Kopecky SL, Holmes DR, Jr., Frye RL (2001) T-cell immunity in acute coronary syndromes. Mayo Clin Proc 76:1011–1020PubMedCrossRefGoogle Scholar
  37. Yamori Y, Horie R, Akiguchi I, Kihara M, Nara Y, Lovenberg W (1982) Symptomatological classification in the development of stroke in strokeprone spontaneously hypertensive rats. Jpn Circ J 46:274–283PubMedCrossRefGoogle Scholar
  38. Zoldhelyi P, Beck PJ, Bjercke RJ, Ober JC, Hu X, McNatt JM, Akhtar S, Ahmed M, Clubb FJ, Jr., Chen ZQ, Dixon RA, Yeh ET, Willerson JT (2000) Inhibition of coronary thrombosis and local inflammation by a noncarbohydrate selectin inhibitor. Am J Physiol Heart Circ Physiol 279:H3065–3075PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2004

Authors and Affiliations

  • H. Takeda
  • M. Spatz
  • C. Ruetzler
  • R. McCarron
  • K. Becker
  • J. Hallenbeck

There are no affiliations available

Personalised recommendations